151 related articles for article (PubMed ID: 38161493)
1. Differential Mortality Outcomes in Real-world Patients with Lean, Nonobese, and Obese Nonalcoholic Fatty Liver Disease.
Nguyen VH; Ha A; Rouillard NA; Le RH; Fong A; Gudapati S; Park JE; Maeda M; Barnett S; Cheung R; Nguyen MH
J Clin Transl Hepatol; 2023 Dec; 11(7):1448-1454. PubMed ID: 38161493
[TBL] [Abstract][Full Text] [Related]
2. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
3. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
[TBL] [Abstract][Full Text] [Related]
4. The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan.
Lin CL; Tai CM; Huang JF; Liu CJ; Chen HF; Cheng PN; Chen CY; Peng CY; Wang CC; Weng SH; Tseng TC; Kao JH
J Gastroenterol Hepatol; 2022 Oct; 37(10):1901-1910. PubMed ID: 35790343
[TBL] [Abstract][Full Text] [Related]
5. Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD.
Chakrabarty M; Jha AN; Sharma DJ
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443531
[TBL] [Abstract][Full Text] [Related]
6. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
[TBL] [Abstract][Full Text] [Related]
7. Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease.
Sookoian S; Pirola CJ
Aliment Pharmacol Ther; 2018 Jan; 47(1):16-25. PubMed ID: 29083036
[TBL] [Abstract][Full Text] [Related]
8. Lean Patients with Non-Alcoholic Fatty Liver Disease Have a Severe Histological Phenotype Similar to Obese Patients.
Denkmayr L; Feldman A; Stechemesser L; Eder SK; Zandanell S; Schranz M; Strasser M; Huber-Schönauer U; Buch S; Hampe J; Paulweber B; Lackner C; Haufe H; Sotlar K; Datz C; Aigner E
J Clin Med; 2018 Dec; 7(12):. PubMed ID: 30562976
[TBL] [Abstract][Full Text] [Related]
9. Lean Americans With Nonalcoholic Fatty Liver Disease Have Lower Rates of Cirrhosis and Comorbid Diseases.
Weinberg EM; Trinh HN; Firpi RJ; Bhamidimarri KR; Klein S; Durlam J; Watkins S; Reddy KR; Weiss M; Zink RC; Lok AS
Clin Gastroenterol Hepatol; 2021 May; 19(5):996-1008.e6. PubMed ID: 32629123
[TBL] [Abstract][Full Text] [Related]
10. Liver-related Mortality is Increased in Lean Subjects with Non- alcoholic Fatty Liver Disease Compared to Overweight and Obese Subjects.
Feldman A; Wernly B; Strebinger G; Eder SK; Zandanell S; Niederseer D; Strasser M; Haufe H; Sotlar K; Paulweber B; Datz C; Aigner E
J Gastrointestin Liver Dis; 2021 Sep; 30(3):366-373. PubMed ID: 34375373
[TBL] [Abstract][Full Text] [Related]
11. Impact of body mass index on disease progression and outcomes in patients with nonalcoholic fatty liver disease.
Biswas S; Vaishnav M; Farooqui N; Aggarwal A; Pathak P; Yadav R; Das P; Elhence A; Goel A; Mishra AK; Shalimar
Postgrad Med J; 2023 Sep; 99(1176):1094-1103. PubMed ID: 37308443
[TBL] [Abstract][Full Text] [Related]
12. Natural History of Nonalcoholic Fatty Liver Disease With Normal Body Mass Index: A Population-Based Study.
Ahmed OT; Gidener T; Mara KC; Larson JJ; Therneau TM; Allen AM
Clin Gastroenterol Hepatol; 2022 Jun; 20(6):1374-1381.e6. PubMed ID: 34265444
[TBL] [Abstract][Full Text] [Related]
13. Higher mortality among lean patients with non-alcoholic fatty liver disease despite fewer metabolic comorbidities.
Wijarnpreecha K; Li F; Lundin SK; Suresh D; Song MW; Tao C; Chen VL; Lok ASF
Aliment Pharmacol Ther; 2023 May; 57(9):1014-1027. PubMed ID: 36815445
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic fatty liver disease in lean subjects: Prognosis, outcomes and management.
Chrysavgis L; Ztriva E; Protopapas A; Tziomalos K; Cholongitas E
World J Gastroenterol; 2020 Nov; 26(42):6514-6528. PubMed ID: 33268944
[TBL] [Abstract][Full Text] [Related]
15. Clinical, anthropometric, biochemical, and histological characteristics of nonobese nonalcoholic fatty liver disease patients of Bangladesh.
Alam S; Gupta UD; Alam M; Kabir J; Chowdhury ZR; Alam AK
Indian J Gastroenterol; 2014 Sep; 33(5):452-7. PubMed ID: 25023045
[TBL] [Abstract][Full Text] [Related]
16. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
Akyuz U; Yesil A; Yilmaz Y
Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
[TBL] [Abstract][Full Text] [Related]
17. Sex-specific Cutoff Values of Visceral Fat Area for Lean vs. Overweight/Obese Nonalcoholic Fatty Liver Disease in Asians.
Lee S; Kim KW; Lee J
J Clin Transl Hepatol; 2022 Aug; 10(4):595-599. PubMed ID: 36062272
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease (NAFLD) in lean individuals - Single centre large cohort clinicopathologic and immunophenotypic study.
Rastogi A; Rath I; Varadarajan A; Ramakrishna G; Bihari C; Maiwall R
Pathol Res Pract; 2022 Oct; 238():154112. PubMed ID: 36126451
[TBL] [Abstract][Full Text] [Related]
19. Comparative Burden of Metabolic Dysfunction in Lean NAFLD vs Non-lean NAFLD - A Systematic Review and Meta-analysis.
Tang A; Ng CH; Phang PH; Chan KE; Chin YH; Fu CE; Zeng RW; Xiao J; Tan DJH; Quek J; Lim WH; Mak LY; Wang JW; Chew NWS; Syn N; Huang DQ; Siddiqui MS; Sanyal A; Muthiah M; Noureddin M
Clin Gastroenterol Hepatol; 2023 Jul; 21(7):1750-1760.e12. PubMed ID: 35863685
[TBL] [Abstract][Full Text] [Related]
20. Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Ye Q; Zou B; Yeo YH; Li J; Huang DQ; Wu Y; Yang H; Liu C; Kam LY; Tan XXE; Chien N; Trinh S; Henry L; Stave CD; Hosaka T; Cheung RC; Nguyen MH
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):739-752. PubMed ID: 32413340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
